Fundsmith Investment Services LTD. Has $435.37 Million Stake in Waters Corporation $WAT

Fundsmith Investment Services LTD. cut its holdings in Waters Corporation (NYSE:WAT) by 15.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,146,209 shares of the medical instruments supplier’s stock after selling 210,080 shares during the period. Waters accounts for 8.0% of Fundsmith Investment Services LTD.’s investment portfolio, making the stock its 2nd biggest position. Fundsmith Investment Services LTD. owned approximately 1.92% of Waters worth $435,365,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Graham Capital Management L.P. bought a new position in Waters in the 4th quarter worth approximately $337,000. Beacon Investment Advisors LLC bought a new position in Waters in the 4th quarter worth approximately $205,000. Aster Capital Management DIFC Ltd boosted its holdings in Waters by 2,686.1% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 7,634 shares of the medical instruments supplier’s stock worth $2,900,000 after buying an additional 7,360 shares during the period. Oddo BHF Asset Management Sas boosted its holdings in Waters by 28.8% in the 4th quarter. Oddo BHF Asset Management Sas now owns 7,850 shares of the medical instruments supplier’s stock worth $2,982,000 after buying an additional 1,756 shares during the period. Finally, OMERS ADMINISTRATION Corp boosted its holdings in Waters by 249.3% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 7,413 shares of the medical instruments supplier’s stock worth $2,816,000 after buying an additional 5,291 shares during the period. 94.01% of the stock is owned by institutional investors.

Waters Trading Up 0.9%

Shares of WAT stock opened at $360.87 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.13 and a current ratio of 1.79. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $414.15. The company has a market capitalization of $35.43 billion, a PE ratio of 45.85, a price-to-earnings-growth ratio of 2.16 and a beta of 1.21. The business’s fifty day moving average is $339.89 and its 200 day moving average is $349.20.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter last year, the business posted $2.25 earnings per share. The firm’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, equities research analysts anticipate that Waters Corporation will post 14.51 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $350.00 price objective on shares of Waters in a report on Thursday, May 7th. JPMorgan Chase & Co. raised their price target on shares of Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Barclays upped their price target on shares of Waters from $400.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Bank of America increased their price objective on Waters from $370.00 to $400.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 2nd. Finally, The Goldman Sachs Group upgraded Waters to a “strong-buy” rating in a research report on Wednesday, April 1st. Three research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $394.56.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.